Logo Syntekabio.png
Syntekabio Signs Memorandum of Understanding with bioSeedin/ACROBiosystems
20 juin 2024 10h00 HE | Syntekabio USA Inc.
DAEJEON, South Korea, June 20, 2024 (GLOBE NEWSWIRE) -- Syntekabio (KOSDAQ: 226330), an artificial intelligence (AI) based drug development company, announced the signing of a strategic Memorandum...